Status:
ENROLLING_BY_INVITATION
Prospective Breast Cancer Biobanking
Lead Sponsor:
Helse Stavanger HF
Collaborating Sponsors:
Helse-Bergen HF
Conditions:
Breast Cancer
Eligibility:
FEMALE
18-85 years
Brief Summary
Prospective Breast Cancer Biobanking study (PBCB) will apply advanced monitoring in liquid biopsies of early staged breast cancer ration in order to facilitate A. Early detection of systemic relapses ...
Detailed Description
A. Early detection of systemic relapses in breast cancer. WP 1. Analysis of primary tumor. Analysis of primary tumor and metastases (Pathology group). In this work package both DNA and RNA from the ...
Eligibility Criteria
Inclusion
- Early stage Breast Cancer
- DCIS gr III
Exclusion
- Not able to read Norwegian
- Not able to communicate in Norwegian
- Previously diagnosed with cancer
- Dementia
Key Trial Info
Start Date :
September 1 2011
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
July 15 2030
Estimated Enrollment :
1200 Patients enrolled
Trial Details
Trial ID
NCT04488614
Start Date
September 1 2011
End Date
July 15 2030
Last Update
July 30 2020
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Helse Stavanger HF
Stavanger, Rogaland, Norway, 4068
2
Helse Bergen HF
Bergen, Vestland, Norway, 5021